Cross-sectional analysis examines drug price and rebate impact on coverage restrictions in US health plans, suggesting cost implications.
This cross-sectional study examines the association of drug prices and rebates with health plan coverage restrictions in the US.
No takes yet. Share an insight, caveat, or question.
Beinfeld et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: